Investors

Home » investors » Press Releases

Press Releases


Investor Tools

  • Email page
  • PDF view
  • Print view
  • Email Alert
  • RSS Feeds
  • Tearsheet
  • Mobile IR Site
  • Social Media Sharing
  • Email page
  • PDF view
  • Print view
  • Email Alert
  • RSS Feeds
  • Tearsheet
  • Mobile IR Site
  • Social Media Sharing

Year:
DateHeadlineFormat
5/08/2013Coronado Biosciences Reports Financial Results for the First Quarter Ended March 31, 2013

5/07/2013Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease

5/06/2013Coronado Biosciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

5/01/2013Coronado Biosciences to Report First Quarter 2013 Financial Results

4/24/2013Coronado Biosciences Announces Departure of Dr. Bobby W. Sandage, Jr.

4/11/2013Coronado Biosciences Announces Sale of Common Stock in Its At-the-Market Public Offering

4/03/2013Coronado Biosciences to Host Analyst Event in New York City

3/14/2013Coronado Biosciences Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012

3/11/2013Coronado Biosciences to Present at the ROTH 25th Annual Growth Stock Conference

3/07/2013Coronado Biosciences to Report Fourth Quarter and Full Year 2012 Results

2/27/2013Coronado Biosciences to Present at the Cowen and Co. 33rd Annual Health Care Conference

2/25/2013Coronado Biosciences Announces Initiation of Investigator-Initiated Study Evaluating TSO in Psoriasis

2/22/2013Coronado Biosciences Signs Research Collaboration and License Agreement With Freie Universitat Berlin for Secretory Products of Trichuris suis

2/19/2013Coronado Biosciences to Participate in Panel Discussion at the Citi 2013 Global Healthcare Conference

2/07/2013Coronado Biosciences to Present at the Leerink Swann 2013 Global Healthcare Conference

1/02/2013Coronado Biosciences Announces Key Addition to Management Team

12/27/2012Coronado Biosciences Acquires TSO Manufacturing Rights From Ovamed

12/21/2012Coronado Biosciences Announces Phase 2 Study Evaluating TSO in Ulcerative Colitis

12/05/2012Coronado Biosciences to Present at the Oppenheimer 23rd Annual Healthcare Conference

11/28/2012Coronado Initiates Phase 1/2 Trial of CNDO-109 Activated Allogeneic Natural Killer Cells in Acute Myeloid Leukemia

Click the link to the right to download: Adobe Acrobat
Source: SNL Financial LC
Rows 1 through 20 of 76